The Washington Post has a pretty good story today documenting how one of the greatest impediments to passing strong, progressive health care reform in the House — the Blue Dog coalition — has experienced an upsurge in campaign contributions in recent months, from among others, the health insurance industry:
[T]he [Blue Dogs] set a record pace for fundraising this year through its political action committee, surpassing other congressional leadership PACs in collecting more than $1.1 million through June. More than half the money came from the health-care, insurance and financial services industries, marking a notable surge in donations from those sectors compared with earlier years, according to an analysis by the Center for Public Integrity. […]
A look at career contribution patterns also shows that typical Blue Dogs receive significantly more money — about 25 percent — from the health-care and insurance sectors than other Democrats, putting them closer to Republicans in attracting industry support.
Great. Not exactly earth-shattering revelations, but good to see the Post giving the Blue Dogs a hard time. What I wanted to remark upon, though, is the defense offered by founding Blue Dog member and current health care lobbyist Charles Stenholm. He explains:
The idea behind giving to a group like the Blue Dogs is that you believe that they will agree with your positions most of the time. … The same is true for liberals or anyone else. It’s normal in politics.
The business of influence and access peddling in Washington is often thinly veiled in pseudo-respectable claims that industry groups donate to candidates who they believe are predisposed to agree with their public policy priorities. But I think it is more accurate to say that industries donate to individuals who they perceive as predisposed to being bought. Indeed, if the health insurance industry really based its contribution decisions on who they thought would be more likely sympathize with their desire to keep the health care system as it is, they would do well to always direct a majority of their cash to GOP candidates. But they don’t.
Apparently viewing House candidates as commodities to be bought, they appear to invest in the party that they believe will be in a position to most directly affect their industry’s future. The hope it seems is that their contributions will make their industry’s calls to stall reform a bit louder than the public’s calls for significant changes to the health care system in the U.S.
Take a look at this graph of health insurance contributions to members of the House since 1990 that I complied using data from OpenSecrets.org. In every House campaign cycle in the last 20 years the health insurance industry has invested quite literally in the status quo — choosing to funnel a majority of their campaign funds to members of the ruling party in the House:
The swing in contributions is particularly pronounced in the 2008 campaign cycle when promises of health care reform from Democratic House candidates were not in short supply. While the figures are for the Democratic caucus as a whole — not the Blue Dogs in particular — the point remains the same: the health care industry is not investing in agreeable philosophies as Stenholm claims. Rather, they are investing in power, influence, and access.
This is hardly a novel point on my part. But I think it’s important to keep in mind as we watch individuals who campaigned on and for the Obama agenda work to block or water down that agenda in the House. While I have not looked at the data, I expect there would be similar trends in the Senate.